Are you searching for effective medications to treat 'Alpha-1 Antitrypsin Deficiency'? This comprehensive guide provides the latest information on medications-both generic and branded-that are ...

The biotech company tested its experimental treatment in patients with alpha-1 antitrypsin deficiency. In this condition, the liver doesn't make enough — or any — of the AAT protein.

In our in vivo portfolio, the BEAM-302 clinical program in alpha-1 antitrypsin deficiency is expanding globally, with dosing complete for the first cohort of patients and data anticipated in 2025 ...

A slew of pharma mergers and acquisitions in the first month of 2024 has continued with a $2.2 billion play by Sanofi for Inhibrx and its clinical-stage drug candidate for alpha-1 antitrypsin ...

his parents were heavy smokers and he had a hereditary predisposition to COPD due to alpha 1 antitrypsin deficiency. Terry Coker, COPD Patient I actually am, I know this sounds crazy, I'm in ...

Narrator Then there's a particularly lethal mix: a genetic, or hereditary predisposition due to alpha 1 antitrypsin deficiency. Diane Kay, COPD Patient I was diagnosed with alpha 1 in '99 but I ...

Key achievements include proof-of-mechanism for RNA editing in alpha-1 antitrypsin deficiency, promising interim data in Duchenne muscular dystrophy, and progress in the development of treatments ...